A detailed history of Rhumbline Advisers transactions in Outset Medical, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 69,117 shares of OM stock, worth $266,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,117
Previous 66,445 4.02%
Holding current value
$266,100
Previous $359,000 57.38%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$1.99 - $5.64 $5,317 - $15,070
2,672 Added 4.02%
69,117 $153,000
Q4 2023

Feb 08, 2024

SELL
$3.07 - $10.25 $2,253 - $7,523
-734 Reduced 1.09%
66,445 $359,000
Q3 2023

Nov 09, 2023

SELL
$10.52 - $20.68 $915 - $1,799
-87 Reduced 0.13%
67,179 $730,000
Q2 2023

Aug 08, 2023

BUY
$17.18 - $23.76 $37,984 - $52,533
2,211 Added 3.4%
67,266 $1.47 Million
Q1 2023

May 11, 2023

BUY
$18.25 - $30.26 $44,146 - $73,198
2,419 Added 3.86%
65,055 $1.2 Million
Q4 2022

Feb 14, 2023

BUY
$12.36 - $26.41 $27,315 - $58,366
2,210 Added 3.66%
62,636 $1.62 Million
Q3 2022

Nov 10, 2022

BUY
$14.67 - $21.7 $72,235 - $106,850
4,924 Added 8.87%
60,426 $963,000
Q2 2022

Aug 11, 2022

BUY
$13.46 - $48.16 $85,578 - $306,201
6,358 Added 12.94%
55,502 $825,000
Q1 2022

May 12, 2022

BUY
$34.22 - $47.24 $68,440 - $94,480
2,000 Added 4.24%
49,144 $2.23 Million
Q4 2021

Feb 10, 2022

BUY
$43.29 - $58.77 $38,744 - $52,599
895 Added 1.94%
47,144 $2.17 Million
Q3 2021

Nov 12, 2021

BUY
$36.86 - $54.98 $73,019 - $108,915
1,981 Added 4.48%
46,249 $2.29 Million
Q2 2021

Aug 05, 2021

BUY
$41.49 - $59.92 $1.45 Million - $2.09 Million
34,898 Added 372.44%
44,268 $2.21 Million
Q1 2021

May 06, 2021

SELL
$46.94 - $58.66 $6,055 - $7,567
-129 Reduced 1.36%
9,370 $510,000
Q4 2020

Feb 10, 2021

BUY
$42.51 - $64.0 $403,802 - $607,936
9,499 New
9,499 $540,000

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $185M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.